Centerra Gold Q1 EPS $0.19, Inline, Sales $295.22M Down From $401.85M YoY
Centerra Gold (NYSE:CGAU) reported quarterly earnings of $0.19 per share which met the analyst consensus estimate. This is a 32.14 percent decrease over earnings of $0.28 per share from the same period last year. The
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Earnings Scheduled For February 25, 2022
Companies Reporting Before The Bell
• ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million.
Centerra Gold Q3 EPS $0.12 Beats $0.09 Estimate; Cuts Guidance
Centerra Gold (NYSE:CGAU) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.09 by 33.33 percent.
Earnings Scheduled For November 5, 2021
Companies Reporting Before The Bell
• Brookfield Renewable (NYSE:BEPC) is projected to report earnings for its third quarter.
5 Value Stocks In The Basic Materials Sector
The Meaning Behind Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
CIBC Upgrades Centerra Gold to Neutral
CIBC analyst Anita Soni upgrades Centerra Gold (TSX:CG) from Underperform to Neutral.
Centerra Gold Q2 EPS $0.17, Sales $202.30M Up From $130.00M YoY
Centerra Gold (NYSE:CGAU) reported quarterly earnings of $0.17 per share. The company reported $202.30 million in sales this quarter. This is a 55.62 percent increase over sales of $130.00 million the same period last
Earnings Scheduled For August 10, 2021
Companies Reporting Before The Bell
• Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter.